Denub 60mg Injection

About

Denub 60mg Injection is a highly effective medication designed to address various conditions involving bone loss and fragility. Its active ingredient is a monoclonal antibody that specifically targets and inhibits RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). By blocking RANKL, this medication prevents the formation, function, and survival of osteoclasts, which are the primary cells responsible for breaking down bone tissue. This targeted action leads to a significant reduction in bone resorption, resulting in increased bone mineral density and enhanced bone strength, thereby substantially lowering the risk of fractures.

This injection is particularly indicated for the treatment of postmenopausal osteoporosis in women at high risk of fracture, as well as for increasing bone mass in men with osteoporosis. It is also used to manage bone loss in patients receiving certain hormone-ablative therapies for prostate or breast cancer. Administered subcutaneously, Denub 60mg offers a convenient and effective treatment regimen, typically given every six months, which helps ensure consistent therapeutic benefits and enhances patient compliance with long-term therapy.

Uses

• Treatment of postmenopausal osteoporosis.
• Increases bone mass in men with osteoporosis.
• Bone loss associated with hormone ablation for prostate cancer.
• Bone loss associated with adjuvant aromatase inhibitor therapy for breast cancer.

Directions For Use

Administered subcutaneously by a healthcare professional, typically once every six months. Ensure adequate calcium and vitamin D intake.

Benefits

• Significantly increases bone mineral density.
• Reduces the risk of vertebral and non-vertebral fractures.
• Convenient dosing schedule (typically twice yearly).
• Effective in various bone loss conditions.
• Well-tolerated by most patients.
• Offers a non-bisphosphonate option for bone health.

Side Effects

• Back pain.
• Musculoskeletal pain.
• Pain in extremities.
• Hypercholesterolemia.
• Cystitis.
• Upper respiratory tract infection.
• Hypocalcemia (low calcium levels).
• Osteonecrosis of the jaw (rare).
• Atypical femoral fractures (rare).
• Skin rash.
• Cellulitis.
• Allergic reactions.

Safety Measures

• Alcohol - No known direct interaction, but excessive alcohol consumption can negatively impact bone health.
• Pregnancy - Contraindicated due to potential for fetal harm; effective contraception is required during treatment.
• Breastfeeding - Not recommended; potential for excretion in breast milk and harm to the infant.
• Liver - No dose adjustment needed; generally considered safe for patients with liver conditions.
• Kidney - Use with caution in severe renal impairment; monitor calcium levels closely.
• Lung - No specific contraindication or dose adjustment required for lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.